POSB270 Does Orphan Drug Status Confer Any Benefits for Products Undergoing HTA Appraisal By NICE in England?
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.873
https://www.valueinhealthjournal.com/article/S1098-3015(21)02668-1/fulltext
Title :
POSB270 Does Orphan Drug Status Confer Any Benefits for Products Undergoing HTA Appraisal By NICE in England?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02668-1&doi=10.1016/j.jval.2021.11.873
First page :
Section Title :
Open access? :
No
Section Order :
10405